Dr Mohit Saxena Senior Consultant: Medical Oncology Marengo Asia Hospitals, Gurugram (NCR)

Senior Consultant: Medical Oncology

Education

MBBS - Sawai Man Singh Medical College & Hospital, Jaipur, Rajasthan
MD (General medicine) - Sawai Man Singh Medical College & Hospital, Jaipur, Rajasthan
DM (Medical Oncology) - Gujarat Cancer & Research Institute, Ahmedabad, Gujarat

About the Doctor

Dr. Mohit Saxena is a renowned Medical Oncologist with experience of over 10 years.
He has been extensively trained in the management of cancer patients at the Prestigious GCRI, Ahmedabad.
He moved to Delhi-NCR and worked at various hospitals to expand his experience in management of solid and hematological cancers.
He has rich experience in cancer research and has published numerous papers and research articles in national and international journals.

Expertise

Immunotherapy
Chemotherapy {Intravenous, Intrathecal, intraperitoneal (HIPEC), Oral Metronomic Therapy}
Targeted therapy and Precision Medicine
Hormone therapy
Biotherapy
Management of- Head & Neck Cancers
Breast cancer
Lung Cancer
Gastrointestinal cancers (Esophagus/ Stomach/Colon/Rectal)
Hepatobiliary & pacreatic cancers (Liver /Pancreas/Bile duct/Gallbladder)
Female Genitourinary Cancers (Cervix /Uterus/Ovary)
Hematological malignancies (Lymphoma /Myeloma/Leukaemia)
Bone and soft tissue sarcoma
Malignant Melanoma

Past Experience

Senior Resident (Medical Oncology) at Gujarat Cancer & Research Institute, Ahmedabad Mar 2016 - Sept 2016
Consultant (Medical Oncology) at Artemis Hospital, Gurugram Nov 2016 June 2019
Consultant (Medical Oncology) at C. K. Birla Hospital, Gurugram June 2019 - August 2020 Consultant (Medical Oncology) at Paras Hospital, Gurugram July 2019-Dec 2019 Empaneled Consultant (Medical Oncology) at Fortis Hospital, Vasant Kunj, New Delhi Jan 2020 August 2020
Consultant (Medical Oncology) at Narayana Superspeciality Hospital, Gurugram

Publications

Saxena M, Madabhavi I, Patel A et al. Treating low-and intermediate risk acute promyelocytic leukemia with and without chemotherapy: A comparison in a tertiary care center. Journal of Cancer Research and Therapeutics. 2023 Apr; DOI: 10.4103 /jcrt.jcrt_436_21
Saxena M. Madabhavi I, Patel A et al. Experience of Sorafenib as First-Line Treatment in Metastatic Renal Cell Carcinoma in a Tertiary Care Centre. Int J Hematol Oncol Stem Cell Res 2018 Jul 1; 12(3): 197-203.
Saxena M, Panchal H P, Parikh SK et al. High dose Cytarabinearabinoside (Ara-C) as a culprit of leukoencephalopathyin a patient of acute myeloid leukemia. Vidarbha Journal of Internal Medicine 2015 July; 19: 63-66.
Genitourinary cancers (Prostate/Testis /Urinary Bladder/Kidney)